Pfizer-BioNTech COVID-19 Vaccine Now Available for Children Ages 5-11

Once the Council approves these proposals, the financial support will be provided in the form of loans granted on favourable terms from the EU to Member States. The first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force. The contract will allow the purchase of a vaccine against COVID-19 for all the EU Member States, as well as the donation to lower and middle income countries or the re-direction to other European countries. Through the contract, all Member States will be able to purchase 300 million doses of the AstraZeneca vaccine, with an option for further 100 million doses, to be distributed on a population-based pro-rata basis.

The European Commission has complemented the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Following new offers of assistance from EU Member States to countries in need, the Commission has so far supported the sharing of over 3 million COVID-19 vaccines with countries outside of the EU through the European Civil Protection Mechanism. The Commission decided to prolong until 30 June 2022 the State aid Temporary Framework . In order to further accelerate the recovery, the Commission has also decided to introduce two new measures to create direct incentives for forward-looking private investment and solvency support measures, for an additional limited period. In its first bond syndication of 2022, the Commission raised a further €5 billion in NextGenerationEU funds on behalf of the EU in yet another successful deal. Due on 6 July 2051, the 30-year bond – executed as an increase to an existing EU-Bond – brings the total financing raised under the programme to €78.5 billion.

The EIB financing is backed by both Horizon2020 InnovFin and the European Fund for Strategic Investments. On 24 June 2020, the second of two EU Humanitarian Air Bridge flights arrived in Sudan, helping humanitarian workers and essential supplies reach people in need and supporting the coronavirus response in the country. This fully EU-funded Humanitarian Air Bridge tinkmarkets forex broker review flight to Sudan was made possible through a coordinated Team Europe approach, bringing together the European Union, Sweden, France and the Humanitarian Logistics Network. Countries supported include Afghanistan, Burkina Faso, the Central African Republic, the Democratic Republic of Congo, Iran, Sudan, South Sudan, Haiti, Somalia, Guinea Bissau, Iraq and Yemen.

The EU and AstraZeneca have reached an agreement which will secure the delivery of the remaining COVID-19 vaccine doses to Member States under the terms of the Advance Purchase Agreement concluded on 27 August 2020 with AstraZeneca. The European Commission issued the first NextGenerationEU green bond, thus raising €12 billion to be used exclusively for green and sustainable investments across the EU. Based on the recommendation of the European Medicines Agency, the Commission authorised the first two COVID-19 booster vaccines adapted to variants, from BioNTech Pfizer and Moderna. Our mission is to end childhood health epidemics by working aggressively to eliminate harmful exposures, hold those responsible accountable, and to establish safeguards to prevent future harm. Though a COVID-19 vaccine could certainly boost Pfizer’s fortunes, the big drugmaker’s future success doesn’t depend on it. It had already made significant progress with this program when it announced a partnership with Pfizer in March.

Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

The protection of employment was crucial to facilitate the rapid economic rebound in 2021, which was faster than in previous crises. SURE helped to enable this by financing schemes to allow firms to retain employees and skills, and to help the self-employed to be ready to resume their activities immediately, as well as by boosting confidence across the EU. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

The dose for 5–11 year olds is different from the dose authorized for people ages 12 and older, and children in this age group should not receive the 12 and older dose. “Children are vulnerable to the COVID-19 virus just like everyone else,” said NCDHHS Secretary Mandy K. Cohen, M.D. “The authorization of the Pfizer-BioNTech vaccine provides a safe, tested way to protect them from serious illness and provide healthier, happier experiences in and outside of the classroom.” You can trade stocks with FOREX.com from some jurisdictions using spread-bets or CFDs, with spreads from 0.1%. Very simply, all big pharma firms like Pfizer make money by charging health providers, whether in the private and public sector, for the medicines it produces. They make a profit when the revenue they collect from selling medicines outweighs their capital expenditure.

The Commission proposed a macro-financial assistance package worth €3 billion for ten enlargement and neighbourhood partners to help them limit the economic fallout of the coronavirus pandemic. The proposal comes on top of the ‘Team Europe’ strategy, the EU’s robust and targeted response to support partner countries’ efforts in tackling the coronavirus pandemic. The Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. The Council adopted a regulation establishing the Recovery and Resilience Facility, which lies at the heart of the EU’s recovery plan. EU countries will receive support from the facility on the basis of their national recovery and resilience plans, which are currently under preparation.

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

The Commission disbursed €2.25 billion to Germany in pre-financing, equivalent to 9% of the country’s financial allocation under the Recovery and Resilience Facility. The pre-financing payment will help kick-start the implementation of the crucial investment and reform measures outlined in Germany’s recovery and resilience plan. The Commission disbursed €201 million to Denmark in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility.

That’s above the 2.8% Dow Jones estimate, but represents a slight cooldown from the third-quarter reading. As an immediate first response, EU Member States mobilised and delivered a total of 12 tons of protective equipment to China. The first out of four joint procurements of personal protective equipment was launched together with Member States. This turns the EU into one big buyer, encouraging suppliers to move quickly at scale and provide the maximum equipment possible at the best price. As of 24 March, producers have made offers covering, and in some cases even exceeding, the quantities requested.

The Commission presented a Communication on the early lessons learnt from the COVID-19 pandemic over the past 18 months and building on them to improve action at EU and national level. This will help to better anticipate public health risks and enhance contingency planning leading to swifter and more effective joint responses at all levels. These therapeutics will bring treatment to patients across the EU as fast as possible provided that their safety and effectiveness has been confirmed by the European Medicines Agency. The Commission proposed to extend the EU Digital COVID Certificate by a year, until 30 June 2023. Extending the Regulation will ensure that travellers can continue using their EU Digital COVID Certificate when travelling in the EU where Member States maintain certain public health measures. The Commission proposed a set of actions to manage the current phase of the COVID-19 pandemic and prepare for the next one.

It will enable Poland to emerge stronger from the COVID-19 pandemic and progress with the green and digital transitions. The Commission gave a positive assessment of the Netherlands’ recovery and resilience plan. This is a key step paving the way for the EU to disburse €4.7 billion in grants to the Netherlands under the Recovery and Resilience Facility. This financing will support the implementation of the crucial investment and reform measures outlined in the Netherlands’ recovery and resilience plan.

Croatia has received e510 million, Cyprus e250 million, Greece €2 billion, Italy an additional E€6.5 billion, Latvia e120 million, Lithuania €300 million, Malta €120 million, Slovenia e200 million and Spain an additional €4 billion. The Commission has disbursed €8.5 billion in the third instalment of financial support to five Member States under the SURE instrument. Belgium has received EUR 2 billion, Hungary €200 million, Portugal E€3 billion, Romania EUR 3 billion and Slovakia €300 million. This support, in the form of loans granted on favourable terms, will assist Member States in addressing sudden increases in public expenditure to preserve employment. With this disbursement, 15 Member States have received around EUR 40 billion under the EU SURE instrument between the end of October and the end of November. The Commission granted a conditional marketing authorisation for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU.

Additional exceptional measures were proposed to further support agricultural and food markets most affected. The European Commission has set up an EU Humanitarian Air Bridge to transport humanitarian workers and emergency supplies for the coronavirus response to some of most critical areas around the world. The Council adopted the Commission’s proposal for a temporary derogation from the rules governing “European Companies ” and the European Cooperative Society , only four weeks after the Commission had proposed it. The measures will allow European Companies and the European Cooperative Societies to exceptionally hold their general meetings within twelve months of the end of the financial year, instead of within six months as provided for in the legislation. To ensure the recovery is sustainable, even, inclusive and fair for all Member States, the European Commission has proposed to create a new recovery instrument, Next Generation EU, embedded within a powerful, modern and revamped long-term EU budget.

They will also have the possibility to purchase vaccines for an additional 200 million people. The Commission has already signed a contract with AstraZeneca and with Sanofi-GSK and concluded successful arum capital overview exploratory talks with CureVac, BioNTech-Pfizer and Moderna. The Commission disbursed €915 million to Czechia in a pre-financing payment under the Recovery and Resilience Facility.

Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

It consisted of a new 3-year bond of €6 billion due on 4 July 2025 and a €3 billion tap of an existing 30-year bond due on 6 July 2051. This is the first 3-year bond the Commission has issued under its diversified funding strategy. HERA, the European Commission’s Health Preparedness and Response Authority, signed a joint procurement Framework Contract with the company HIPRA HUMAN HEALTH for the supply of their protein COVID-19 vaccine. 14 Member States and countries are participating in this joint procurement, under which they can purchase up to 250 million doses. The company is currently evaluating its mRNA COVID-19 vaccine in early stage clinical studies.

• The Commission approved a sixth contract under the EU Vaccines Strategy, with the pharmaceutical company Moderna.
• The Commission adopted a proposal for a Council Recommendation to ensure that any measures taken by Member States that restrict free movement due to the coronavirus pandemic are coordinated and clearly communicated at the EU level.
• According to an industry report from the drug analytics and contract research organization IQVIA Holdings , global expenditure on medicine is likely to reach $1.9 trillion by 2027, increasing in the range of 3% to 6% …
• This is an important step towards the EU disbursing a total of €1.2 billion in grants and loans under the Recovery and Resilience Facility and will play a key role in enabling Cyprus to emerge stronger from the COVID-19 pandemic.

The European Commission has granted a conditional marketing authorisation for the COVID‑19 vaccine developed by Novavax. The European Commission has today issued €8 billion in a dual tranche transaction under the NextGenerationEU recovery instrument. The deal was the 11th syndicated transaction under NextGenerationEU and the 6th in 2022.

What 10 Analyst Ratings Have To Say About Pfizer

But there could be another way to play the reopening, with Bank of America and UBS having identified a raft of less obvious beneficiaries outside of China. Stocks in certain key sectors that are directly related to China’s reopening, such as domestic consumption and travel, have done well in recent months. Was up 0.6% in early trade, with financial services adding 1.3% to lead gains as most sectors and major bourses entered positive territory. Higher inflation and input costs, in addition to permitting delays and supply chain shortages mean that the company’s growth outlook remains tricky. Chinese electric vehicle stocks also rose, with Nio and Xpeng jumping jumping more than 6% each. Directorate General for Health and Safety opened an alert notification on the Early Warning and Response System where most Member States have since been sharing information on response and communication measures.

This is an important step towards the EU disbursing €3.5 billion in grants under the Recovery and Resilience Facility and will help Austria emerge stronger from the COVID-19 pandemic. The Commission disbursed €800 million in payments under NextGenerationEU, the temporary instrument to finance Europe’s recovery and foster a greener, more digital and resilient economy after the pandemic. The payments went to 41 national and regional programmes in 16 Member States from theRecovery Assistance for Cohesion and the Territories of Europe initiative (REACT-EU).

Pfizer Inc

This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency and is endorsed by the EU countries. The Commission proposed immediate action to prepare Europe for the increased threat of coronavirus variants, including through the new European bio-defence preparedness plan called“HERA Incubator” . €9 billion were disbursed to seven EU countries in the fifth instalment of financial support under the SURE instrument. Czechia received €1 billion, Spain €2.87 billion, Croatia €510 million, Italy €3.87 billion, Lithuania €302 million, Malta €123 million and Slovakia €330 million. These loans will assist EU countries in addressing sudden increases in public expenditure to preserve employment. To date, 16 EU countries have received a total of €62.5 billion under the SURE instrument in back-to-back loans.

Pfizer-BioNTech COVID-19 Vaccine Now Available for Children Ages 5-11

The pre-financing payment will help to kick-start the implementation of the crucial investment and reform measures outlined in Malta’s recovery and resilience plan. The Commission disbursed €271 million to Finland in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility. The pre-financing payment will help kick-start the implementation of the crucial investment and reform measures outlined in Finland’s recovery and resilience plan. It will provide critical and targeted support in key areas such as health, water, sanitation and hygiene. The newly adopted package brings the total assistance mobilised through the EU Trust Fund to over €2.2 billion since 2015, doubling the target originally set.

J.P. Morgan USD EM Bond

Pfizer expects $99.5 billion to $102 billion in sales and adjusted earnings of $6.40-$6.50 a share. Sales of blood thinner Eliquis and pneumonia vaccine Prevnar climbed a respective 9% and 11%. The company also announced plans to form a new company with Roivant Sciences to sell a drug currently in development for ulcerative colitis.

In April the Commission approved 127 State aid measures to support businesses and protect livelihoods across Europe during the coronavirus outbreak. We continue working closely with EU countries to ensure our economy can bounce back strongly after the crisis. 1.5 million medical masks will be delivered to 17 Member States and the UK to protect healthcare workers. The Commission has adopted a third amendment to extend the scope of the State aid Temporary Framework adopted on 19 March 2020 that wouldenable Member States to further support micro, small and start-up companies.

VIR-7832 could potentially be used to treat COVID-19 and as a vaccine to prevent infection. In addition, the biotech is conducting preclinical studies of an inhaled therapy targeting COVID-19. It’s not brokerage company prtrend surprising that the Bill & Melinda Gates Foundation also owns shares of BioNTech. Again, though, the nonprofit foundation didn’t invest in the German biotech stock because of its coronavirus program.

The European Commission proposed to activate the EU’s Emergency Support Instrument on 2 April to directly support the Member States’ healthcare systems in their fight against the pandemic. On 14 April, the Council gave its fast approval, so that the €2.7 billion instrument can immediately begin providing direct support where most needed. They aim to support Member States in effectively using testing tools in the context of their national strategies and during the different stages of the pandemic, including when phasing out confinement measures.

The RRF is providing up to €723.8 billion of grants and loans to Member States to support transformative investments and reforms that will enable the EU to emerge stronger from the COVID-19 pandemic. The report shows that major headway has been made and confirms that the implementation of the RRF is well underway. The Commission granted a marketing authorisation for the COVID‑19 vaccine developed by Valneva, the sixth COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation by the European Medicines Agency . The company recently began a phase 2/3 clinical study with its partner, GlaxoSmithKline, evaluating an antibody therapy targeting COVID-19. Vir expects to initiate a phase 2 study of another COVID-19 antibody therapy, VIR-7832, later this year.